Delayed left ventricular mass reduction with sustained antihypertensive treatment: The LIFE study

被引:0
|
作者
Devereux, RB [1 ]
Palmieri, V [1 ]
Liu, JE [1 ]
Wachtell, K [1 ]
Boman, K [1 ]
Gerdts, E [1 ]
Nieminen, MS [1 ]
Papademetriou, V [1 ]
Dahlof, B [1 ]
机构
[1] Cornell Univ, Weill Med Ctr, New York, NY USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:287A / 287A
页数:1
相关论文
共 50 条
  • [41] Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment
    Aznaouridis, Konstantinos A.
    Vyssoulis, Gregory P.
    Karpanou, Eva A.
    Marinakis, Andreas G.
    Barbetseas, John D.
    Zervoudaki, Alexandra U.
    Cokkinos, Dennis V.
    Stefanadis, Christodoulos I.
    BLOOD PRESSURE MONITORING, 2007, 12 (02) : 87 - 94
  • [43] Changes in left ventricular geometry during antihypertensive treatment
    Salvetti, Massimo
    Paini, Anna
    Bertacchini, Fabio
    Stassaldi, Deborah
    Aggiusti, Carlo
    Rosei, Claudia Agabiti
    Bassetti, Davide
    Agabiti-Rosei, Enrico
    Muiesan, Maria Lorenza
    PHARMACOLOGICAL RESEARCH, 2018, 134 : 193 - 199
  • [44] Regression of left ventricular hypertrophy during antihypertensive treatment
    Foading Deffo, Bertin
    ACTA CARDIOLOGICA, 2006, 61 (04) : 485 - 488
  • [45] Regression of Left Ventricular Mass by Antihypertensive Treatment A Meta-Analysis of Randomized Comparative Studies
    Fagard, Robert H.
    Celis, Hilde
    Thijs, Lutgarde
    Wouters, Stijn
    HYPERTENSION, 2009, 54 (05) : 1084 - 1091
  • [46] Impact of isolated systolic hypertension on normalization of left ventricular structure during antihypertensive treatment in patients with electrocardiographic left ventricular hypertrophy (LIFE)
    Mancusi, C.
    Gerdts, E.
    De Simone, G.
    Abdelhai, Y. M.
    Lonnebakken, M. T.
    Boman, K.
    Wachtell, K.
    Dahlof, B.
    Devereux, R. B.
    EUROPEAN HEART JOURNAL, 2013, 34 : 597 - 597
  • [47] Change in systolic left ventricular performance after 3 years of antihypertensive treatment -: The Losartan intervention for Endpoint (LIFE) study
    Wachtell, K
    Palmieri, V
    Olsen, MH
    Gerdts, E
    Papademetriou, V
    Nieminen, MS
    Smith, G
    Dahlöf, B
    Aurigemma, GP
    Devereux, RB
    CIRCULATION, 2002, 106 (02) : 227 - 232
  • [48] Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass:: the LIFE study
    Okin, PM
    Devereux, RB
    Liu, JE
    Oikarinen, L
    Jern, S
    Kjeldsen, SE
    Julius, S
    Wachtell, K
    Nieminen, MS
    Dahlöf, B
    JOURNAL OF HUMAN HYPERTENSION, 2004, 18 (06) : 403 - 409
  • [49] Regression vs progression of ECG left ventricular hypertrophy and changes in left ventricular mass: The LIFE study
    Okin, PM
    Liu, JE
    Jern, S
    Kjeldsen, SE
    Wachtell, K
    Dahof, B
    CIRCULATION, 2000, 102 (18) : 606 - 606
  • [50] Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: the LIFE study
    P M Okin
    R B Devereux
    J E Liu
    L Oikarinen
    S Jern
    S E Kjeldsen
    S Julius
    K Wachtell
    M S Nieminen
    B Dahlöf
    Journal of Human Hypertension, 2004, 18 : 403 - 409